Drug Treatment Value in a Changing Oncology Landscape: A Literature and Provider Perspective
Author:
Affiliation:
1. Analysis Group, Boston, Massachusetts.
2. Novartis Pharmaceuticals, East Hanover, New Jersey.
Publisher
Academy of Managed Care Pharmacy
Subject
Health Policy,Pharmaceutical Science,Pharmacy
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United States;Journal of Managed Care & Specialty Pharmacy;2023-09
2. May value-based healthcare practices contribute to comprehensive care for cancer patients? A systematic literature review;Journal of Cancer Policy;2022-12
3. Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience;Journal of Clinical Medicine;2021-01-07
4. Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea;Journal of Korean Medical Science;2021
5. Formulary management challenges and opportunities: 2020 and beyond ‐ an opinion paper of the drug information practice and research network of the American College of Clinical Pharmacy;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2020-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3